Alithea Genomics develops sample-preparation kits for large-scale RNA sequencing (BRB-seq, DRUG-seq). It has added CHF 3 million to its seed round, bringing it to CHF 6.9 million, to commercialise its 1,536-well DRUG-seq kits.
- Announced on
- Round
- Seed
- Amount
- CHF 6.9 M
- Location
- Epalinges, canton of Vaud
- Sector
- Biotech & life sciences
Investors
- Genku Ventures lead
- Novalis Biotech
- Zürcher Kantonalbank
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic